.After revealing a phase 3 launch based upon positive midstage end results, iTeos as well as GSK are...
.The FDA should be actually more available and collective to unleash a rise in commendations of unco...
.It's an abnormally occupied Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bicar...
.Atea Pharmaceuticals' antiviral has actually neglected an additional COVID-19 trial, but the biotec...
.Neurocrine Biosciences' mental illness plan pivot has stopped working. The biotech was not able to ...
.Sanofi has created a late entry to the radioligand event, paying 100 million euros ($ 110 thousand)...
.After F2G's very first attempt to get a brand-new class of antifungal to market was actually derail...
.Moderna has promised to reduce R&D investing through $1.1 billion by 2027. The selection to retr...
.Just 4 months after Sanofi bet $80 thousand in upfront money on Fulcrum Therapeutics' losmapimod, t...
.Cancer company Oncternal Therapies is folding all its scientific tests and also giving up team, tra...